|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1994-2-10
|
|
pubmed:abstractText |
Both behavior-modification methods and antidepressants have proved to be effective in the treatment of agoraphobia. The authors examined the effects of clomipramine on agoraphobia in patients who failed to respond to exposure-based behavioral treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
481-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8276739-Adult,
pubmed-meshheading:8276739-Agoraphobia,
pubmed-meshheading:8276739-Behavior Therapy,
pubmed-meshheading:8276739-Clomipramine,
pubmed-meshheading:8276739-Combined Modality Therapy,
pubmed-meshheading:8276739-Double-Blind Method,
pubmed-meshheading:8276739-Drug Administration Schedule,
pubmed-meshheading:8276739-Female,
pubmed-meshheading:8276739-Hospitalization,
pubmed-meshheading:8276739-Humans,
pubmed-meshheading:8276739-Male,
pubmed-meshheading:8276739-Panic Disorder,
pubmed-meshheading:8276739-Placebos,
pubmed-meshheading:8276739-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
|
|
pubmed:affiliation |
Research Institute, Modum Bads Nervesanatorium, Vikersund, Norway.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
